The amino acid sequence of the monovalent VHH construct BL3.1 and the bivalent VHH construct BL3.2, with the complementary-determining regions (CDRs) highlighted. The bivalent BL3.2 was created by gen
Therapeutic blockade of the CD47/SIRPα axis by small molecules or monoclonal antibodies (mAbs) is a proven strategy to enhance macrophages-mediated anti-tumor activity. However, this strategy has been
Lower respiratory tract infections, such as infections caused by influenza A viruses, are a constant threat for public health. Antivirals are indispensable to control disease caused by epidemic as wel
CRYSTAL STRUCTURE OF FC P329G LALA WITH ANTI FC P329G FAB Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)
